ALX Oncology Holdings, Inc. (ALXO)

1.47 +0.03 (+2.08%) USD  |  NASDAQ  |  Dec 09, 13:48
More

ALX Oncology Holdings EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ALXO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Prelude Therapeutics, Inc. Upgrade
Werewolf Therapeutics, Inc. Upgrade
Erasca, Inc. Upgrade
Immuneering Corp. Upgrade